Work

Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas

Year: 2026

Type: erratum

Source: Journal of Clinical Oncology

DOI: 10.1200/jco-26-00231

Authors: Jaishri O. Blakeley, Xiaobu Ye, Dan G. Duda, Chris F. Halpin, Amanda L. Bergner, Alona Muzikansky, Vanessa L. Merker, Elizabeth R. Gerstner, Laura M. Fayad, Shivani Ahlawat, Michael A. Jacobs, Rakesh K. Jain, Christopher Zalewski, Eva Dombi, Brigitte C. Widemann, Scott R. Plotkin

Language: English

Topic: Meningioma and schwannoma management

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7128479409

Cites:

Cited by:

Related to: